
<!DOCTYPE html>
<html dir="ltr" lang="zh-CN">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link rel="preconnect" href="https://www.googletagmanager.com">
<link rel="dns-prefetch" href="https://www.google-analytics.com">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- Diagnostic info: Cookie Law information is not enabled for current language. -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="zh-CN">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="zh-CN">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>癌症的免疫治疗 - 血液病学及肿瘤病学 - MSD诊疗手册专业版</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
<!-- Diagnostic info: TopicMultimediaStructuredData - Topic Resources string is null or empty. --> 
 
 
<!-- Google Tag Manager -->
<script></script>
<!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "zh-CN",
 Code: "zh"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "33507451-91a1-4adb-b50c-0ab017d4409e";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v978209_zh";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "0d7cf13b-1168-471a-90f8-a707b78332d1",
 VasontId : "v978073_zh"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "c09d09ec-cb3a-4c21-8033-07ddbe02c814",
 VasontId : "v878838_zh"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "zh-CN";
 MManual.settings.languageCode = "zh";
 MManual.settings.displayDateFormat = "yy-MM-dd";
 MManual.settings.dateFormat = "yy-MM-dd";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['Common.Letters.Alphabet'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=Lf2mEc1mNu26ayS3cHvJyIfMnm0MoeX0377nXTzTN181" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">默沙东 诊疗手册 </span>
 </div>
 <div class="confirmationpopup__description">
 <p>欢迎来到默沙东诊疗手册专业版医讯网站 本网站旨在为医药专业人员提供在线服务，如果您不是医药专业人员，建议您退出网站，登录默沙东中国官方网站了解相关信息。如您并非医药专业人员，不论您基于任何原因访问或浏览本网站，您同意均不应参考本网站内容作为诊断、治疗、预防、康复、使用医疗产品或其他任何产品的建议或意见，对此您应寻求执业医师及其他具备相应资质的专业人士意见并遵照医嘱。本网站所载信息绝无意代替您自己的医学判断并且本网站刊载的任何观点、评论和其他内容亦无意作为可以信赖的建议，因此，我们郑重声明因任何本网站访问者或任何获知本网站内容者基于对本网站材料的信赖所引起的任何责任与义务都与本网站无关。您同意默沙东将不对您使用和/或依赖本网站内容、产品、信息或者资讯导致的直接或间接损失承担任何责任，并不对网站内容及其引述的产品、方法、资讯或其他材料的准确性、时效性、可适用性承担任何明示或暗示的保证责任。默沙东诊疗手册网站将对所有注册用户信息进行验证，您必须接受并遵守用户协议条款才能使用本网站。如注册人员信息没能通过验证，默沙东诊疗手册网站有权终止该用户使用本网站的权利，在本网站下方均有链接功能，您可随时通过链接浏览用户使用协议条款与网站保护政策。</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">我是专业医学人士</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">我不是专业医学人士</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script></script>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">要离开本网站吗？</span>
 </div>
 <div class="confirmationpopup__description">
 <p>您选择的链接将带您前往第三方网站。我们无法控制任何第三方网站的内容或对其负责。</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">继续</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">取消 </a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">音频</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 展示详情
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 隐藏详情
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D 模型</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 展示详情
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 隐藏详情
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">资料来源：</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">实验室检测</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: '实验室检测' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: '实验室检测',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Common.AriaLabels.ExpandPopup'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 关闭
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="上一个" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="下一个" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 展示详情
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 隐藏详情
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="打印">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2023 Merck & Co., Inc., Rahway, NJ, USA 及其附属公司。保留所有权利。
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.cn/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.cn/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">临床计算器：</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">在这些主题中</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd zh ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) -->
<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<!-- End Google Tag Manager (noscript) -->
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="33507451-91a1-4adb-b50c-0ab017d4409e">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.cn/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="zh-CN">
<input type="hidden" id="currentLanguage2LetterISO" value="zh">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="
选择语言">
<input type="hidden" id="commonCloseText" value="关闭">
<input type="hidden" id="readAllText" value="全部读取">
 
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Common.AriaLabels.SocialMediaShare"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="打印"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="邮件"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="下一个:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 癌症的免疫治疗
 </h1>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">作者： </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/gale-robert.html">Robert Peter Gale</a></strong>
 <p class="topic__authors--description">, MD, PhD, DSC(hc), Imperial College London</p>
 <div class="topic__revision">
 <div class="topic__authors">
 医学审查 5月 2023 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="MM358;MM346" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 看法 进行患者培训
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v978216_zh" class="topicmenu_mobile__paragraph">被动性细胞免疫治疗</a>
 </li>
 <li>
 <a href="#v978226_zh" class="topicmenu_mobile__paragraph">被动性体液免疫治疗</a>
 </li>
 <li>
 <a href="#v978235_zh" class="topicmenu_mobile__paragraph">主动特异性免疫治疗</a>
 </li>
 <li>
 <a href="#v26337223_zh" class="topicmenu_mobile__paragraph">免疫治疗和免疫反应的靶向抑制剂</a>
 </li>
 <li>
 <a href="#v978250_zh" class="topicmenu_mobile__paragraph">非特异性免疫治疗</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__accordion">
 <span id="v978215_zh" class="anchor"></span><div class="para"> <p>许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 <a href="./{423A7772-7958-4BEA-9306-0EE1887D5A9E}.html" data-toggle="tooltip" title="免疫治疗" data-id="8b4a9c22-d23e-43e7-839c-5de928c01598" data-itemid="423a7772-7958-4bea-9306-0ee1887d5a9e">免疫治疗</a><span id="8b4a9c22-d23e-43e7-839c-5de928c01598" class="d-none xref"> <span class="tooltip-container"> <a href="./{423A7772-7958-4BEA-9306-0EE1887D5A9E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫治疗 </span> 免疫治疗剂的应用或 免疫机制的修正。这些制剂的使用快速发展；新的种类、新的制剂，以及当前使用制剂的新用法，也在一定程度上发展。 大量不同种类的免疫治疗制剂已经出现。（见表 一些临床使用的免疫治疗药物）： 单克隆抗体 融合蛋白 可溶性细胞因子受体 重组细胞因子 <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>）</p></div> <section id="v978216_zh" class="topic__section FHead" itemprop="associatedAnatomy" itemscope="" itemtype="http://schema.org/AnatomicalStructure"> <h2 id="Other_v978217_zh" class="topic__header--section"> <span id="v978217_zh" class="anchor"></span> 被动性细胞免疫治疗 </h2> <div class="topic__content"> <span id="v978218_zh" class="anchor"></span><div class="para"> <p>在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。</p></div><span id="v978219_zh" class="anchor"></span><div class="para"> <p><b>淋巴因子激活的杀伤细胞（LAK细胞）</b> 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体中的临床试验正在进行中，但这种方法尚未得到广泛应用，通常被认为不如其他细胞疗法有效。</p></div><span id="v978221_zh" class="anchor"></span><div class="para"> <p><b>肿瘤浸润性淋巴细胞（TILs）</b>可能比LAK细胞具有更强的肿瘤杀伤活性。这些细胞的培养方法与LAK细胞相似。然而，祖细胞是由手术切除的肿瘤组织中分离出来的T细胞组成的。从理论上讲，这一过程产生的T细胞比血液中获得的T细胞具有更强的肿瘤特异性。临床研究显示前景广阔（<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347633_zh" data-toggle="tooltip" title="被动细胞免疫治疗参考文献" data-id="cc41acff-b357-4aec-926d-b908396848c6" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">1</a><span id="cc41acff-b357-4aec-926d-b908396848c6" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347633_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 被动细胞免疫治疗参考文献 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>）。</p></div><span id="v26337215_zh" class="anchor"></span><div class="para"> <p><b>基因修饰的T细胞</b> 能够表达</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v26337218_zh" class="anchor"></span><div class="para"> <p><b> T细胞受体</b> （TCR），能识别对肿瘤细胞具有高度特异性的 <a href="./{8BDF738D-A4F3-43A3-BCC1-D5253B8A6C63}.html" data-toggle="tooltip" title="肿瘤抗原" data-id="b4a5c84c-f5c7-4553-a406-7d444ce00436" data-itemid="8bdf738d-a4f3-43a3-bcc1-d5253b8a6c63">肿瘤相关抗原</a><span id="b4a5c84c-f5c7-4553-a406-7d444ce00436" class="d-none xref"> <span class="tooltip-container"> <a href="./{8BDF738D-A4F3-43A3-BCC1-D5253B8A6C63}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 肿瘤抗原 </span> 许多肿瘤细胞能产生抗原，这些抗原可被释放到血液中或者留在细胞表面。任何能被免疫系统识别的分子都被称作抗原。大多数恶性肿瘤中都能检测到抗原，如 伯基特淋巴瘤、 神经母细胞瘤、 黑色素瘤、 骨肉瘤、 肾细胞癌、 乳腺癌、 前列腺癌、 肺癌和 结肠癌。免疫系统的主要功能是识别和清除这些抗原。... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>（TAA）。这种方法已经让位于 CAR-T 细胞（见下文）</p></div></li><li class="topic__listitem"><span id="v26337220_zh" class="anchor"></span><div class="para"> <p><b>嵌合抗原受体</b> （CAR）能识别肿瘤细胞表面的特异蛋白。CAR T 细胞用于 B 细胞患者 <a href="./{5DC5F1E1-42FF-4542-BD26-984FD37805FD}.html" data-toggle="tooltip" title="淋巴瘤的概述" data-id="7b42f5ed-024f-4d21-8860-ac9434f76ecf" data-itemid="5dc5f1e1-42ff-4542-bd26-984fd37805fd">淋巴瘤</a><span id="7b42f5ed-024f-4d21-8860-ac9434f76ecf" class="d-none xref"> <span class="tooltip-container"> <a href="./{5DC5F1E1-42FF-4542-BD26-984FD37805FD}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 淋巴瘤的概述 </span> 淋巴瘤是起源于网状内皮系统和淋巴系统的一组异质性恶性肿瘤。主要类型是 霍奇金淋巴瘤 非霍奇金淋巴瘤 见表 霍奇金淋巴瘤与非霍奇金淋巴瘤的比较 淋巴瘤以前被认为是与 白血病完全不同的疾病。然而，随着对细胞标志物及评估细胞标志物的方法的深入了解，人们发现这2种肿瘤的区别常常是很模糊的。至少在疾病的早期，... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>, <a href="./{4A309E41-DE77-4B9A-B966-341C87ED9233}.html" data-toggle="tooltip" title="急性淋巴细胞白血病（ALL）" data-id="1240f23d-7102-4088-a1f4-b7e38d4ffac9" data-itemid="4a309e41-de77-4b9a-b966-341c87ed9233">急性淋巴细胞白血病</a><span id="1240f23d-7102-4088-a1f4-b7e38d4ffac9" class="d-none xref"> <span class="tooltip-container"> <a href="./{4A309E41-DE77-4B9A-B966-341C87ED9233}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 急性淋巴细胞白血病（ALL） </span> 急性淋巴细胞白血病（ALL）是儿童最常见的恶性肿瘤，它也可以出现在成人的各个年龄段。 异常分化的、长寿命的造血祖细胞发生恶性转化和异常增殖，导致血液循环中出现大量的原始细胞，而正常的骨髓被恶性细胞取代，并可浸润CNS和睾丸。 症状包括疲劳、面色苍白、感染、骨痛，中枢神经系统症状(如头痛)、容易瘀伤和出血。通常用外周血涂片和骨髓检查来诊断。治疗通常包括联合化疗以获得缓解；鞘内注射和全身化疗和/或皮质类固醇预防CNS浸润，有时脑照射治疗脑内... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/p/e/r/peripheral_blood_blast_cell_high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="急性淋巴细胞白血病（ALL）" loading="lazy"> </span> </a> </span> </span>， 和 <a href="./{A3E9CBB2-F7B3-4B55-B48F-918F631D9495}.html" data-toggle="tooltip" title="多发性骨髓瘤" data-id="4d11d5e5-beb9-4ebf-a640-0d76b7da7a99" data-itemid="a3e9cbb2-f7b3-4b55-b48f-918f631d9495">浆细胞骨髓瘤</a><span id="4d11d5e5-beb9-4ebf-a640-0d76b7da7a99" class="d-none xref"> <span class="tooltip-container"> <a href="./{A3E9CBB2-F7B3-4B55-B48F-918F631D9495}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 多发性骨髓瘤 </span> 多发性骨髓瘤是一种恶性浆细胞病，产生单克隆免疫球蛋白，侵犯并破坏邻近的骨组织。常见临床表现包括引起疼痛和/或骨折的溶骨性病变、肾功能不全、高钙血症、贫血和反复感染。诊断通常需证实存在M蛋白（有时存在于尿液中，不存在于血清中，但很少完全缺失）和/或轻链蛋白尿，以及骨髓中过多的浆细胞。特异性治疗常包括传统化疗、糖皮质激素和一种或多种新药组合如蛋白酶体抑制剂(硼替佐米、卡非佐米、伊莎佐米)... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/u/l/multiple_myeloma_joyce_high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="多发性骨髓瘤" loading="lazy"> </span> </a> </span> </span> （<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347633_zh" data-toggle="tooltip" title="被动细胞免疫治疗参考文献" data-id="ca23c402-1445-4218-83b2-b48446acbc85" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">2, 3</a><span id="ca23c402-1445-4218-83b2-b48446acbc85" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347633_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 被动细胞免疫治疗参考文献 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>）。</p></div></li></ul></div><span id="v26337221_zh" class="anchor"></span><div class="para"> <p>与TCR T细胞不同的是，CAR T细胞只识别肿瘤细胞表面相对较大分子的蛋白。因此，CAR T细胞和TCR T细胞可能是互补的癌症治疗方法。</p></div><span id="v978223_zh" class="anchor"></span><div class="para"> <p>同时使用干扰素提高了肿瘤细胞表面主要组织相容性复合物(MHC)和TAAs的表达，从而增强了输入的效应细胞杀死肿瘤细胞的作用。</p></div> <section id="v68347632_zh" class="topic__section GHead"> <span></span> <h3 id="Other_v978217_zh_v68347633_zh" class="topic__header--subsection"> <span id="v68347633_zh" class="anchor"></span> 被动细胞免疫治疗参考文献 </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v68347636_zh" class="anchor"></span><div class="para"> <p>1.<a rel="nofollow" target="_blank" href="https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-021-02006-4">Wang S, Sun J, Chen K, et al</a>: Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors.<i>BMC Med</i> 19, 140 (2021).https://doi.org/10.1186/s12916-021-02006-4</p></div></li><li class="topic__listitem"><span id="v80808083_zh" class="anchor"></span><div class="para"> <p>2.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/29567707/">June CH, O'Connor RS, Kawalekar OU, et al</a>: CAR T cell immunotherapy for human cancer. <i>Science</i> 359(6382):1361-1365, 2018.doi:10.1126/science.aar6711</p></div></li><li class="topic__listitem"><span id="v80808086_zh" class="anchor"></span><div class="para"> <p>3.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/23550147/">Sadelain M, Brentjens R, Rivière I</a>: The basic principles of chimeric antigen receptor design. <i>Cancer Discov</i> 3(4):388-398, 2013.doi:10.1158/2159-8290.CD-12-0548</p></div></li></ul></div> </div> </section> </div> </section> <section id="v978226_zh" class="topic__section FHead" itemprop="associatedAnatomy" itemscope="" itemtype="http://schema.org/AnatomicalStructure"> <h2 id="Other_v978227_zh" class="topic__header--section"> <span id="v978227_zh" class="anchor"></span> 被动性体液免疫治疗 </h2> <div class="topic__content"> <span id="v978228_zh" class="anchor"></span><div class="para"> <p>被动性体液免疫治疗是应用外源性抗体的免疫治疗方法。抗淋巴细胞血清已用于治疗慢性淋巴细胞白血病、T细胞淋巴瘤和B细胞淋巴瘤，可引起一过性的淋巴细胞减少或淋巴结缩小，已经开发出更新的体液免疫治疗方式。</p></div><span id="v68347638_zh" class="anchor"></span><div class="para"> <p><b>T细胞接合剂</b> 是招募细胞毒性 T 细胞杀死肿瘤细胞的双特异性抗体。最常用的接合剂是针对T细胞（主要是CD3）上的一种肿瘤抗原和一种分子的抗体。针对两种肿瘤抗原和CD3的抗体正在测试中。T 细胞参与者在 B 细胞前体患者中表现出临床益处 <a href="./{4A309E41-DE77-4B9A-B966-341C87ED9233}.html" data-toggle="tooltip" title="急性淋巴细胞白血病（ALL）" data-id="92b37648-a350-44ac-83e5-776b0d5f758f" data-itemid="4a309e41-de77-4b9a-b966-341c87ed9233">急性淋巴细胞白血病</a><span id="92b37648-a350-44ac-83e5-776b0d5f758f" class="d-none xref"> <span class="tooltip-container"> <a href="./{4A309E41-DE77-4B9A-B966-341C87ED9233}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 急性淋巴细胞白血病（ALL） </span> 急性淋巴细胞白血病（ALL）是儿童最常见的恶性肿瘤，它也可以出现在成人的各个年龄段。 异常分化的、长寿命的造血祖细胞发生恶性转化和异常增殖，导致血液循环中出现大量的原始细胞，而正常的骨髓被恶性细胞取代，并可浸润CNS和睾丸。 症状包括疲劳、面色苍白、感染、骨痛，中枢神经系统症状(如头痛)、容易瘀伤和出血。通常用外周血涂片和骨髓检查来诊断。治疗通常包括联合化疗以获得缓解；鞘内注射和全身化疗和/或皮质类固醇预防CNS浸润，有时脑照射治疗脑内... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/p/e/r/peripheral_blood_blast_cell_high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="急性淋巴细胞白血病（ALL）" loading="lazy"> </span> </a> </span> </span> 和其他一些血液系统恶性肿瘤。正在研究实体瘤的疗效（<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347642_zh" data-toggle="tooltip" title="被动体液免疫参考" data-id="3bf477e5-ab2a-4fdd-b3a0-806046535f79" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">1</a><span id="3bf477e5-ab2a-4fdd-b3a0-806046535f79" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347642_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 被动体液免疫参考 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>）。</p></div><span id="v978232_zh" class="anchor"></span><div class="para"> <p><b>抗体-药物偶联物 (ADC)</b> 可能用过了。单克隆抗肿瘤抗体也可以与不同的细胞毒性药物或放射性同位素结合，使得抗体选择性地将这些毒性剂递送至肿瘤细胞。例如，人表皮生长因子受体 2 (HER2; ERB2B) 靶向抗体与拓扑异构酶 I 抑制剂结合的 III 期试验证明了对 HER2 阳性转移性乳腺癌患者的临床益处 (2）。其他抗体-药物偶联物包括吉妥珠单抗（急性髓细胞白血病）、维布妥昔单抗（霍奇金病）、奥英妥珠单抗（急性淋巴细胞白血病、慢性淋巴细胞白血病）和泊洛妥珠单抗（<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347642_zh" data-toggle="tooltip" title="被动体液免疫参考" data-id="150d50e3-1b48-486d-8d54-ab58c96fcfb5" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">3, 4</a><span id="150d50e3-1b48-486d-8d54-ab58c96fcfb5" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347642_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 被动体液免疫参考 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>)。</p></div> <section id="v68347641_zh" class="topic__section GHead"> <span></span> <h3 id="Other_v978227_zh_v68347642_zh" class="topic__header--subsection"> <span id="v68347642_zh" class="anchor"></span> 被动体液免疫参考 </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v80808090_zh" class="anchor"></span><div class="para"> <p>1.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/35880455/">Baeuerle PA, Wesche H</a>: T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities. <i>Curr Opin Oncol</i> 34(5):552-558, 2022.doi:10.1097/CCO.0000000000000869</p></div></li><li class="topic__listitem"><span id="v68347645_zh" class="anchor"></span><div class="para"> <p>2.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/35320644/">Cortes J, Kim SB, Chung WP, et al</a>: <span class="genericDrug" data-showrollover="false">Trastuzumab deruxtecan</span> versus <span class="genericDrug" data-showrollover="false">trastuzumab emtansine</span> for breast cancer.<i>N Engl J Med</i> 386(12):1143–1154, 2022. doi: 10.1056/NEJMoa2115022</p></div></li><li class="topic__listitem"><span id="v80808093_zh" class="anchor"></span><div class="para"> <p>3.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/24031011/">Sliwkowski MX, Mellman I</a>: Antibody therapeutics in cancer. <i>Science</i> 341(6151):1192-1198, 2013.doi:10.1126/science.1241145</p></div></li><li class="topic__listitem"><span id="v80808096_zh" class="anchor"></span><div class="para"> <p>4.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/22424219/">Weiner LM, Murray JC, Shuptrine CW</a>: Antibody-based immunotherapy of cancer. <i>Cell</i> 148(6):1081-1084, 2012.doi:10.1016/j.cell.2012.02.034</p></div></li></ul></div> </div> </section> </div> </section> <section id="v978235_zh" class="topic__section FHead" itemprop="associatedAnatomy" itemscope="" itemtype="http://schema.org/AnatomicalStructure"> <h2 id="Other_v978236_zh" class="topic__header--section"> <span id="v978236_zh" class="anchor"></span> 主动特异性免疫治疗 </h2> <div class="topic__content"> <span id="v978237_zh" class="anchor"></span><div class="para"> <p>在一个不能自发形成有效免疫反应的宿主中，诱导 <a href="./{1596166C-F1D9-4F14-987C-5D93937CD3C6}.html#v978129_zh" data-toggle="tooltip" title="细胞免疫" data-id="f448c530-1ed3-4e7d-be31-88fe1ab0b90d" data-itemid="1596166c-f1d9-4f14-987c-5d93937cd3c6">细胞免疫</a><span id="f448c530-1ed3-4e7d-be31-88fe1ab0b90d" class="d-none xref"> <span class="tooltip-container"> <a href="./{1596166C-F1D9-4F14-987C-5D93937CD3C6}.html#v978129_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 细胞免疫 </span> 对外源性抗原的免疫反应包括 体液机制（如抗体） 细胞机制 （参见 肿瘤抗原.) 大多数体液免疫反应不能抑制肿瘤生长。而T细胞、巨噬细胞和自然杀伤细胞等这些效应细胞具有相对有效的肿瘤杀伤能力。效应细胞活性由在其表面上呈递肿瘤特异性抗原（TSAs）或肿瘤相关抗原（TAAs）的其他细胞（这些细胞称为抗原呈递细胞）诱导，并由 细胞因子（例如白细胞介素，干扰素）支持。尽管效应细胞具有活性，但是宿主免疫反应可能无法控制肿瘤的发生和发展。 <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>（包括细胞毒性T细胞）通常涉及增强将肿瘤抗原提呈给宿主效应细胞的能力。细胞免疫可以被诱导针对到特定的、非常明确的抗原。一些技术可以用于刺激宿主的免疫反应，涉及到肽、DNA或肿瘤细胞（来自宿主或另一个患者）。肽和 DNA 可以使用电穿孔或佐剂注射直接、经皮递送至骨髓或树突细胞，或使用抗原呈递细胞（树突细胞）间接递呈。 这些树突状细胞也可以通过基因修饰分泌更多的免疫反应刺激因子（如<span class="genericDrug" data-showrollover="false">粒细胞巨噬细胞集落刺激因子</span>，GM-CSF）。</p></div><span id="v978238_zh" class="anchor"></span><div class="para"> <p><b>肽类疫苗</b>使用的肽来自于特定的TAAs。已经明确，越来越多的TAAs是癌症患者体内T细胞的靶点，正在进行临床试验。最近的数据表明，如果TAAs是由树突状细胞递呈的，那么反应是最有效的。这些细胞是从患者身上获取的，载有所需要的TAA，经过皮内重新注入，刺激内源性T细胞对TAA做出反应。肽类也可以通过与免疫佐剂同时使用来传递 (<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v80808104_zh" data-toggle="tooltip" title="主动特异性免疫治疗参考文献" data-id="2540da46-f367-4ced-8ce4-0fa260f08ae1" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">1</a><span id="2540da46-f367-4ced-8ce4-0fa260f08ae1" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v80808104_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 主动特异性免疫治疗参考文献 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>)。</p></div><span id="v978240_zh" class="anchor"></span><div class="para"> <p><b>DNA疫苗</b>使用重组DNA，其编码特定的（确定的）抗原蛋白。DNA通过经皮电穿孔直接传输被整合到病毒中，然后直接注入患者体内。或者被导入从患者体内获得的树突状细胞中，然后再注射回患者体内。DNA表达的靶抗原能触发或增强患者的免疫反应。DNA疫苗的临床试验已经显示出令人鼓舞的结果 (<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v80808104_zh" data-toggle="tooltip" title="主动特异性免疫治疗参考文献" data-id="ef9732b9-4a10-4219-b4ca-49775bd49966" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">2</a><span id="ef9732b9-4a10-4219-b4ca-49775bd49966" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v80808104_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 主动特异性免疫治疗参考文献 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>)。</p></div><span id="v978243_zh" class="anchor"></span><div class="para"> <p><b>同种异体肿瘤细胞</b>（取自其他患者的细胞）已用于 <a href="./{4A309E41-DE77-4B9A-B966-341C87ED9233}.html" data-toggle="tooltip" title="急性淋巴细胞白血病（ALL）" data-id="2e98b678-00d5-4533-b49b-ba82aefb2dc0" data-itemid="4a309e41-de77-4b9a-b966-341c87ed9233">急性淋巴细胞白血病</a><span id="2e98b678-00d5-4533-b49b-ba82aefb2dc0" class="d-none xref"> <span class="tooltip-container"> <a href="./{4A309E41-DE77-4B9A-B966-341C87ED9233}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 急性淋巴细胞白血病（ALL） </span> 急性淋巴细胞白血病（ALL）是儿童最常见的恶性肿瘤，它也可以出现在成人的各个年龄段。 异常分化的、长寿命的造血祖细胞发生恶性转化和异常增殖，导致血液循环中出现大量的原始细胞，而正常的骨髓被恶性细胞取代，并可浸润CNS和睾丸。 症状包括疲劳、面色苍白、感染、骨痛，中枢神经系统症状(如头痛)、容易瘀伤和出血。通常用外周血涂片和骨髓检查来诊断。治疗通常包括联合化疗以获得缓解；鞘内注射和全身化疗和/或皮质类固醇预防CNS浸润，有时脑照射治疗脑内... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/p/e/r/peripheral_blood_blast_cell_high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="急性淋巴细胞白血病（ALL）" loading="lazy"> </span> </a> </span> </span>和 <a href="./{254F1AF2-71BD-4858-8DF6-D9AF69E77C56}.html" data-toggle="tooltip" title="急性髓系白血病（AML）" data-id="94e82a53-2135-4a64-b153-faff5dcaa85f" data-itemid="254f1af2-71bd-4858-8df6-d9af69e77c56">急性髓细胞白血病</a><span id="94e82a53-2135-4a64-b153-faff5dcaa85f" class="d-none xref"> <span class="tooltip-container"> <a href="./{254F1AF2-71BD-4858-8DF6-D9AF69E77C56}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 急性髓系白血病（AML） </span> 在急性髓系白血病（AML）中，异常分化的、长寿命的髓系造血祖细胞发生恶性转化和不能控制的增殖，导致循环中出现大量不成熟的细胞，且正常骨髓被恶性细胞所取代。症状包括疲乏、面色苍白、易瘀伤及出血、发热和感染；髓外白血病浸润的症状仅出现在5%的患者（常为皮肤表现）。外周血涂片和骨髓检查可明确诊断。治疗包括诱导化疗以达到缓解，以及缓解后化疗（包括或不包括干细胞移植）以避免复发。 也见于... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/7/2/472-leukemia-cutis-localized-slide-5-springer-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="急性髓系白血病（AML）" loading="lazy"> </span> </a> </span> </span>的患者。通过强烈化疗和放射治疗使病情缓解。经过基因或化学修饰的同种异体肿瘤细胞通过辐射增强其潜在的免疫原性，然后再注回患者的体内。有时，还会给患者卡介苗（BCG）疫苗或其他免疫佐剂（一种叫做 <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v978251_zh" data-toggle="tooltip" title="非特异性免疫治疗" data-id="a662444e-fed0-483e-96a3-1421ce85bc73" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">非特异性免疫治疗</a><span id="a662444e-fed0-483e-96a3-1421ce85bc73" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v978251_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 非特异性免疫治疗 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>的治疗方法）以增强抗肿瘤的免疫反应。一些系列研究报道了长期缓解或改善再诱导缓解率，但大多数情况并非如此 (<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v80808104_zh" data-toggle="tooltip" title="主动特异性免疫治疗参考文献" data-id="ae653d4c-6047-43e0-ac37-5fde39ebb32d" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">3</a><span id="ae653d4c-6047-43e0-ac37-5fde39ebb32d" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v80808104_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 主动特异性免疫治疗参考文献 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>)。</p></div><span id="v80808101_zh" class="anchor"></span><div class="para"> <p><b>信使 RNA (mRNA) 疫苗</b> 在SARS-CoV-2大流行期间成功使用，这激发了人们对将其开发为癌症免疫治疗的兴趣（<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v80808104_zh" data-toggle="tooltip" title="主动特异性免疫治疗参考文献" data-id="08175289-ca83-4b42-a53d-696a6107c80d" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">3</a><span id="08175289-ca83-4b42-a53d-696a6107c80d" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v80808104_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 主动特异性免疫治疗参考文献 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>)。</p></div> <section id="v80808103_zh" class="topic__section GHead"> <span></span> <h3 id="Other_v978236_zh_v80808104_zh" class="topic__header--subsection"> <span id="v80808104_zh" class="anchor"></span> 主动特异性免疫治疗参考文献 </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v80808107_zh" class="anchor"></span><div class="para"> <p>1.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34276688/">Stephens AJ, Burgess-Brown NA, Jiang S</a>: Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines. <i>Front Immunol</i> 12:696791, 2021.Published 2021 Jun 30.doi:10.3389/fimmu.2021.696791</p></div></li><li class="topic__listitem"><span id="v80808110_zh" class="anchor"></span><div class="para"> <p>2.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/30953535/">Lopes A, Vandermeulen G, Préat V</a>: Cancer DNA vaccines: current preclinical and clinical developments and future perspectives. <i>J Exp Clin Cancer Res</i> 38(1):146, 2019.doi:10.1186/s13046-019-1154-7</p></div></li><li class="topic__listitem"><span id="v80808113_zh" class="anchor"></span><div class="para"> <p>3.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/35999309/">Lin MJ, Svensson-Arvelund J, Lubitz GS, et al</a>: Cancer vaccines: the next immunotherapy frontier. <i>Nat Cancer</i> 3 (8):911–926, 2022. doi: 10.1038/s43018-022-00418-6</p></div></li></ul></div> </div> </section> </div> </section> <section id="v26337223_zh" class="topic__section FHead"> <h2 id="" class="topic__header--section"> <span id="v26337224_zh" class="anchor"></span> 免疫治疗和免疫反应的靶向抑制剂 </h2> <div class="topic__content"> <span id="v34532501_zh" class="anchor"></span><div class="para"> <p>免疫检查点抑制剂是以自然抑制免疫反应的分子为靶点的一些抗体。这些靶向分子包括：</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v34532504_zh" class="anchor"></span><div class="para"> <p> 细胞毒性T淋巴细胞相关蛋白4（CTLA4）</p></div></li><li class="topic__listitem"><span id="v34532506_zh" class="anchor"></span><div class="para"> <p> 程序性细胞死亡蛋白1（PD1）和程序性细胞死亡配体1（PD-L1）和2（PD-L2）</p></div></li><li class="topic__listitem"><span id="v34532508_zh" class="anchor"></span><div class="para"> <p>其他</p></div></li></ul></div><span id="v34532509_zh" class="anchor"></span><div class="para"> <p><b>细胞毒性T淋巴细胞相关蛋白4 </b> （CTLA-4）可以下调由抗原呈递细胞（APC）活化的CD4 +和CD8 + T细胞的活化。 其机制可能是CTL4对CD80和CD86（共刺激受体）的亲和力高于共刺激受体CD28对APCs的亲和力。 CTLA-4通过激活T细胞受体和细胞因子如干扰素-gamma和白介素-12而上调。CTLA-4抑制剂ipilimumab延长转移性 <a href="./{B016A78E-91B9-47FB-B3D0-EEE3F9C1386A}.html" data-toggle="tooltip" title="黑素瘤" data-id="ea148b0b-0a35-47dd-8dfd-e3a6536f94dd" data-itemid="b016a78e-91b9-47fb-b3d0-eee3f9c1386a">黑色素瘤</a><span id="ea148b0b-0a35-47dd-8dfd-e3a6536f94dd" class="d-none xref"> <span class="tooltip-container"> <a href="./{B016A78E-91B9-47FB-B3D0-EEE3F9C1386A}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 黑素瘤 </span> 恶性黑素瘤来源于色素沉着部位（皮肤、黏膜、眼或中枢神经系统）的黑素细胞。转移与皮肤侵袭的深度相关。肿瘤播散病例的预后很差。诊断依靠活组织检查。对于可切除的肿瘤，广泛切除术是标准方案。转移的病例需要系统治疗，但较难治愈。 （也可以参考 皮肤癌概述。） 2022 年，美国估计将发生约 99.780 例黑色素瘤新病例，估计造成 7650 人死亡（ 1, 2）。白人的终生风险约为 2... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/4/9/449-malignant-melanoma-nonsun-exposed-area-slide-23-springer-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="黑素瘤" loading="lazy"> </span> </a> </span> </span> 的存活时间并且可以用作干扰素的替代物作为高危黑素瘤的辅助治疗 (<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh" data-toggle="tooltip" title="免疫疗法和免疫抑制剂参考" data-id="cc194b84-c106-4518-b315-321317509376" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">1</a><span id="cc194b84-c106-4518-b315-321317509376" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫疗法和免疫抑制剂参考 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>)。Tremelimumab 是另一种 CTLA-4 抑制剂，可用于治疗 <a href="./{1213E244-AC07-4799-B8D9-66E4E27F1E2D}.html#v923748_zh" data-toggle="tooltip" title="分类" data-id="4ab46985-b6b9-40d5-9162-6ce8fecadc76" data-itemid="1213e244-ac07-4799-b8d9-66e4e27f1e2d">非小细胞肺癌</a><span id="4ab46985-b6b9-40d5-9162-6ce8fecadc76" class="d-none xref"> <span class="tooltip-container"> <a href="./{1213E244-AC07-4799-B8D9-66E4E27F1E2D}.html#v923748_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 分类 </span> 肺癌是全球男性和女性癌症相关死亡的主要原因。约85%的患者与吸烟有关。症状包括咳嗽、胸部不适或胸痛、消瘦和咯血（不常见），但很多出现转移的患者有或没有任何临床症状。胸部X线或CT扫描可疑诊，确诊需活检。根据疾病分期，治疗包括外科手术、化疗、放疗，或联合治疗。在过去的几十年，肺癌患者的预后较差，从确诊开始，只有15%的患者能存活超过5年。IV期（转移）患者，5年总体生存率&lt... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/5/5/655-654-sup-vena-cava-syndrome-springer-joined-sized_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="分类" loading="lazy"> </span> </a> </span> </span> （NSCLC）和其他肿瘤（<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh" data-toggle="tooltip" title="免疫疗法和免疫抑制剂参考" data-id="96f8c52a-964c-477f-bdbe-3c1b9855760d" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">2</a><span id="96f8c52a-964c-477f-bdbe-3c1b9855760d" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫疗法和免疫抑制剂参考 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>）。</p></div><span id="v34532512_zh" class="anchor"></span><div class="para"> <p><b> PD-1和PD-L1和2抑制剂</b> 能够抑制由PD-1和PD-L1或PD-L2相互作用激发的某些免疫抑制效应。 PD-1（表达于T细胞、B细胞、NK细胞和一些其他细胞，如单核细胞，树突细胞）与PD-L1（表达于许多肿瘤细胞、造血细胞及其他细胞上）和PD-L2（主要表达于造血细胞）结合。该结合抑制肿瘤细胞凋亡并促进T细胞耗竭和T细胞细胞毒性和辅助性T细胞向调节性T细胞的转化。在肿瘤微环境中，细胞因子如IL-12和IFN-gamma可以上调PD-1和PD-L1/2，阻止T细胞激活和识别肿瘤细胞。</p></div><span id="v68347649_zh" class="anchor"></span><div class="para"> <p>纳武单抗和派姆单抗是IgG4 PD-1抑制剂，可增加T细胞活化和肿瘤浸润，延长转移性 <a href="./{B016A78E-91B9-47FB-B3D0-EEE3F9C1386A}.html" data-toggle="tooltip" title="黑素瘤" data-id="53ce5563-53d7-43c4-935b-4272b7e50d23" data-itemid="b016a78e-91b9-47fb-b3d0-eee3f9c1386a">黑色素瘤</a><span id="53ce5563-53d7-43c4-935b-4272b7e50d23" class="d-none xref"> <span class="tooltip-container"> <a href="./{B016A78E-91B9-47FB-B3D0-EEE3F9C1386A}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 黑素瘤 </span> 恶性黑素瘤来源于色素沉着部位（皮肤、黏膜、眼或中枢神经系统）的黑素细胞。转移与皮肤侵袭的深度相关。肿瘤播散病例的预后很差。诊断依靠活组织检查。对于可切除的肿瘤，广泛切除术是标准方案。转移的病例需要系统治疗，但较难治愈。 （也可以参考 皮肤癌概述。） 2022 年，美国估计将发生约 99.780 例黑色素瘤新病例，估计造成 7650 人死亡（ 1, 2）。白人的终生风险约为 2... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/4/9/449-malignant-melanoma-nonsun-exposed-area-slide-23-springer-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="黑素瘤" loading="lazy"> </span> </a> </span> </span>, <a href="./{1213E244-AC07-4799-B8D9-66E4E27F1E2D}.html" data-toggle="tooltip" title="肺癌" data-id="2b156e87-bfc9-4fce-bb83-794b1b61d97d" data-itemid="1213e244-ac07-4799-b8d9-66e4e27f1e2d">非小细胞肺癌</a><span id="2b156e87-bfc9-4fce-bb83-794b1b61d97d" class="d-none xref"> <span class="tooltip-container"> <a href="./{1213E244-AC07-4799-B8D9-66E4E27F1E2D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 肺癌 </span> 肺癌是全球男性和女性癌症相关死亡的主要原因。约85%的患者与吸烟有关。症状包括咳嗽、胸部不适或胸痛、消瘦和咯血（不常见），但很多出现转移的患者有或没有任何临床症状。胸部X线或CT扫描可疑诊，确诊需活检。根据疾病分期，治疗包括外科手术、化疗、放疗，或联合治疗。在过去的几十年，肺癌患者的预后较差，从确诊开始，只有15%的患者能存活超过5年。IV期（转移）患者，5年总体生存率&lt... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/5/5/655-654-sup-vena-cava-syndrome-springer-joined-sized_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="肺癌" loading="lazy"> </span> </a> </span> </span>, <a href="./{2600DF51-4487-47B9-B3C4-2E45691B4AA4}.html" data-toggle="tooltip" title="口咽部鳞状上皮细胞癌" data-id="b99c540e-c52d-4b50-a9c1-6870638f0f6b" data-itemid="2600df51-4487-47b9-b3c4-2e45691b4aa4">头颈部鳞状细胞癌</a><span id="b99c540e-c52d-4b50-a9c1-6870638f0f6b" class="d-none xref"> <span class="tooltip-container"> <a href="./{2600DF51-4487-47B9-B3C4-2E45691B4AA4}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 口咽部鳞状上皮细胞癌 </span> 口咽部癌症是指扁桃体、三分之一舌基部和后部、软腭、咽后壁和咽后壁的癌症。口咽癌的95％是鳞状细胞癌。吸烟和酗酒是主要的危险因素，但目前多数口咽癌是人乳头状瘤病毒（HPV）导致。症状包括咽喉肿痛，吞咽疼痛和/或困难。治疗是放疗，化疗或二者联合，但初次手术已开始更常用。HPV阳性患者成活率高得多。 头颈部肿瘤概述 2020年在美国，预期有> 18,000 口咽癌新病例 ( 1)。虽然口咽癌的发病率越来越高，其治愈率也提高了。男女比例超过2... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>, <a href="./{4F4ECD0C-2240-4092-811F-8201229536E0}.html" data-toggle="tooltip" title="肾细胞癌" data-id="bc0a4be8-4a4a-4094-8461-0a09a2b4e431" data-itemid="4f4ecd0c-2240-4092-811f-8201229536e0">肾癌</a><span id="bc0a4be8-4a4a-4094-8461-0a09a2b4e431" class="d-none xref"> <span class="tooltip-container"> <a href="./{4F4ECD0C-2240-4092-811F-8201229536E0}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 肾细胞癌 </span> 肾细胞癌是最常见的肾脏肿瘤。症状包括血尿、腰痛、可触及的肿块和不明原因的发热（FUO）。然而，症状往往不存在，所以诊断通常是偶然发现。根据CT或MRI和偶尔靠活检明确诊断。治疗方法包括早期患者行手术治疗，靶向治疗，对晚期患者通常是试验性治疗或姑息治疗。 肾细胞癌（RCC），是一种腺癌，占原发性肾脏恶性肿瘤的90%～95%。其他少见的原发性肾脏肿瘤包括移行细胞癌、 Wilm瘤（常见于儿童）和肉瘤。... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/7/2/9/729-ct-contrast-showing-enhancing-renal-mass-springer-sized_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="肾细胞癌" loading="lazy"> </span> </a> </span> </span>, <a href="./{97D32D79-632B-4FBA-ABBC-E76620568087}.html" data-toggle="tooltip" title="膀胱癌" data-id="78e7e0ae-9663-42f1-8ebb-b928b101d104" data-itemid="97d32d79-632b-4fba-abbc-e76620568087">膀胱癌</a><span id="78e7e0ae-9663-42f1-8ebb-b928b101d104" class="d-none xref"> <span class="tooltip-container"> <a href="./{97D32D79-632B-4FBA-ABBC-E76620568087}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 膀胱癌 </span> 膀胱癌通常为移行细胞（泌尿道上皮）癌。患者通常出现血尿（最常见的），或刺激性排尿症状，如频率和/或紧迫性;随后出现尿路梗阻可引起疼痛。根据膀胱镜和活检诊断。 治疗包括电灼、经尿道电切、膀胱内灌注、根治性手术、化疗、外照射或联合疗法。 美国每年约有>83... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/1/c0105027-cystoscopy-bladder-cancer-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="膀胱癌" loading="lazy"> </span> </a> </span> </span>, 和 <a href="./{18106BC5-54B1-45F6-9F75-493B68F0A3D1}.html" data-toggle="tooltip" title="霍奇金淋巴瘤" data-id="ae8f0bfe-da43-4771-9e7c-0ba4e3ae9014" data-itemid="18106bc5-54b1-45f6-9f75-493b68f0a3d1">霍奇金淋巴瘤</a><span id="ae8f0bfe-da43-4771-9e7c-0ba4e3ae9014" class="d-none xref"> <span class="tooltip-container"> <a href="./{18106BC5-54B1-45F6-9F75-493B68F0A3D1}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 霍奇金淋巴瘤 </span> 霍奇金淋巴瘤是一种淋巴网状系统的局限性或弥漫性的恶性增殖性疾病，主要累及淋巴结、脾脏、肝脏和骨髓。典型症状包括：无痛性淋巴结肿大，有时伴有发热、盗汗、原因不明的体重减轻、瘙痒、脾脏肿大和肝脏肿大。确诊有赖于淋巴结活检。在大多数情况下，治疗是治愈性的，包括有或没有其他治疗方式的化学疗法，包括抗体药物偶联物、免疫疗法和放射疗法。 也见于 淋巴瘤的概述 在美国，每年约有8000例霍奇金淋巴瘤新病例确诊，约900人死于该病。男：女比例为1... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/1/3/m1340534-hodgkin-lymphoma-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="霍奇金淋巴瘤" loading="lazy"> </span> </a> </span> </span>的生存期(<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh" data-toggle="tooltip" title="免疫疗法和免疫抑制剂参考" data-id="f78c46b6-1fc7-42aa-ba2b-2a73c12fb67b" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">3, 4</a><span id="f78c46b6-1fc7-42aa-ba2b-2a73c12fb67b" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫疗法和免疫抑制剂参考 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>)。</p></div><span id="v68347656_zh" class="anchor"></span><div class="para"> <p><b>淋巴细胞激活基因 3 (<i>LAG-3</i>)</b> 通过与肿瘤细胞上的 MHC 相互作用来增加 T 细胞调节剂的活性。封锁 <i>LAG3</i> 单克隆抗体在不可切除的转移性黑色素瘤患者中显示出强大的临床益处（<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh" data-toggle="tooltip" title="免疫疗法和免疫抑制剂参考" data-id="dc6278a8-8e30-4cfd-911d-8aa36aebdd4e" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">5</a><span id="dc6278a8-8e30-4cfd-911d-8aa36aebdd4e" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫疗法和免疫抑制剂参考 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>}。</p></div><span id="v34532515_zh" class="anchor"></span><div class="para"> <p><b>其他正在研究的靶向抑制剂</b>还处于临床开发的较早阶段。这些包括，例如，</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v80808121_zh" class="anchor"></span><div class="para"> <p>B 细胞和 T 细胞淋巴细胞衰减因子 (BTLA)，可减少细胞因子的产生和 CD4 细胞增殖（<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh" data-toggle="tooltip" title="免疫疗法和免疫抑制剂参考" data-id="f13f4c4c-9d62-4b9b-bc25-8ce225b1925d" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">6</a><span id="f13f4c4c-9d62-4b9b-bc25-8ce225b1925d" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫疗法和免疫抑制剂参考 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>)</p></div></li><li class="topic__listitem"><span id="v80808124_zh" class="anchor"></span><div class="para"> <p>杀死辅助性Th1细胞的T细胞免疫球蛋白和粘蛋白结构域3（TIM-3）（<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh" data-toggle="tooltip" title="免疫疗法和免疫抑制剂参考" data-id="ec2f13f2-5436-4239-970c-832b4e8862ae" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">7</a><span id="ec2f13f2-5436-4239-970c-832b4e8862ae" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫疗法和免疫抑制剂参考 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>)</p></div></li><li class="topic__listitem"><span id="v80808127_zh" class="anchor"></span><div class="para"> <p>T细胞活化的V结构域Ig抑制剂（VISTA），其抑制可增加肿瘤中的T细胞活性（<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh" data-toggle="tooltip" title="免疫疗法和免疫抑制剂参考" data-id="bf2cba67-a3d1-4d30-aaaa-4b21adb9ec6d" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">8</a><span id="bf2cba67-a3d1-4d30-aaaa-4b21adb9ec6d" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫疗法和免疫抑制剂参考 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>)</p></div></li></ul></div><span id="v80808129_zh" class="anchor"></span><div class="para"> <p>近年来，已经开发出针对这些分子中的几种的双特异性抗体，目前正在临床试验中进行测试(<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh" data-toggle="tooltip" title="免疫疗法和免疫抑制剂参考" data-id="69f1f4fa-7d0e-4373-b118-5a89bccd975e" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">9</a><span id="69f1f4fa-7d0e-4373-b118-5a89bccd975e" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫疗法和免疫抑制剂参考 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>)。</p></div><span id="v50500313_zh" class="anchor"></span><div class="para"> <p><b>免疫检查点阻滞剂的组合</b> （例如，阻断 CTLA-4 和 PD-1 治疗转移性黑色素瘤或晚期肾细胞癌）正在研究中。临床试验已证明了显着的临床益处，但免疫检查点抑制剂的组合与单一疗法相比具有更高的毒性（<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh" data-toggle="tooltip" title="免疫疗法和免疫抑制剂参考" data-id="7461adc5-0e0e-4702-94d1-e4a07276e03a" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">2</a><span id="7461adc5-0e0e-4702-94d1-e4a07276e03a" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫疗法和免疫抑制剂参考 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>）。</p></div><span id="v68347660_zh" class="anchor"></span><div class="para"> <p><b>结合免疫疗法和常规化学疗法</b> 是一种新的癌症治疗方法。它在涉及各种癌症，疫苗类型和化学疗法的非随机I期和II期临床试验中取得了一些成就（相对于历史对照）。检查点抑制剂派姆单抗 与化学疗法联合用于转移性鳞状非小细胞 <a href="./{1213E244-AC07-4799-B8D9-66E4E27F1E2D}.html" data-toggle="tooltip" title="肺癌" data-id="3e55877b-a6dd-43b3-99d1-e10d3985f3ca" data-itemid="1213e244-ac07-4799-b8d9-66e4e27f1e2d">肺癌</a><span id="3e55877b-a6dd-43b3-99d1-e10d3985f3ca" class="d-none xref"> <span class="tooltip-container"> <a href="./{1213E244-AC07-4799-B8D9-66E4E27F1E2D}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 肺癌 </span> 肺癌是全球男性和女性癌症相关死亡的主要原因。约85%的患者与吸烟有关。症状包括咳嗽、胸部不适或胸痛、消瘦和咯血（不常见），但很多出现转移的患者有或没有任何临床症状。胸部X线或CT扫描可疑诊，确诊需活检。根据疾病分期，治疗包括外科手术、化疗、放疗，或联合治疗。在过去的几十年，肺癌患者的预后较差，从确诊开始，只有15%的患者能存活超过5年。IV期（转移）患者，5年总体生存率&lt... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/6/5/5/655-654-sup-vena-cava-syndrome-springer-joined-sized_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="肺癌" loading="lazy"> </span> </a> </span> </span>的一线治疗 (<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh" data-toggle="tooltip" title="免疫疗法和免疫抑制剂参考" data-id="b83f743f-bfd8-4b3e-86c6-a648347d7ba7" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">10</a><span id="b83f743f-bfd8-4b3e-86c6-a648347d7ba7" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫疗法和免疫抑制剂参考 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>).检查点抑制剂阿替利珠单抗与联合化疗可用于治疗三阴性 <a href="./{C2CC4427-5863-4D84-AFF5-CB0BB1554EE0}.html" data-toggle="tooltip" title="乳腺癌" data-id="171f6a92-2339-4c37-8f95-8cce3b626a70" data-itemid="c2cc4427-5863-4d84-aff5-cb0bb1554ee0">乳腺癌</a><span id="171f6a92-2339-4c37-8f95-8cce3b626a70" class="d-none xref"> <span class="tooltip-container"> <a href="./{C2CC4427-5863-4D84-AFF5-CB0BB1554EE0}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 乳腺癌 </span> 乳腺癌通常是累及导管或小叶的上皮性肿瘤。大多表现为在体格检查或乳房X线片筛查中发现的无症状的肿块。诊断依据活检。治疗通常包括手术切除，通常伴有放射治疗，并伴有或不伴有辅助化疗、内分泌治疗，或两者兼而有之。 在美国，乳腺癌是白人、黑人、亚裔/太平洋岛民、美洲印第安人/阿拉斯加原住民、西班牙女性的第二大癌症死亡原因（仅次于肺癌/支气管癌），也是西班牙裔妇女癌症死亡的主要原因（ 1）。2021... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="乳腺癌" loading="lazy"> </span> </a> </span> </span>患者 (<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh" data-toggle="tooltip" title="免疫疗法和免疫抑制剂参考" data-id="1b42f10c-0807-46ba-9f7d-29a782897859" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">11</a><span id="1b42f10c-0807-46ba-9f7d-29a782897859" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫疗法和免疫抑制剂参考 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>) 。PD-L1 检查点抑制剂 durvalumab 联合化疗已证明对小细胞肺癌患者和常规化疗后对非小细胞肺癌患者的疗效 (<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh" data-toggle="tooltip" title="免疫疗法和免疫抑制剂参考" data-id="26c2d0e3-4d97-4b68-9540-f432573b8bce" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">10</a><span id="26c2d0e3-4d97-4b68-9540-f432573b8bce" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v68347667_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 免疫疗法和免疫抑制剂参考 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>)。</p></div> <section id="v68347666_zh" class="topic__section GHead"> <span></span> <h3 id="" class="topic__header--subsection"> <span id="v68347667_zh" class="anchor"></span> 免疫疗法和免疫抑制剂参考 </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v80808133_zh" class="anchor"></span><div class="para"> <p>1.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/20525992/">Hodi FS, O'Day SJ, McDermott DF, et al</a>: Improved survival with <span class="genericDrug" data-showrollover="false">ipilimumab</span> in patients with metastatic melanoma [published correction appears in <i>N Engl J Med</i> 363(13):1290, 2010]. <i>N Engl J Med</i> 363(8):711-723, 2010.doi:10.1056/NEJMoa1003466</p></div></li><li class="topic__listitem"><span id="v80808137_zh" class="anchor"></span><div class="para"> <p>2.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/36327426/">Johnson ML, Cho BC, Luft A, et al</a>: <span class="genericDrug" data-showrollover="false">Durvalumab</span> with or without <span class="genericDrug" data-showrollover="false">tremelimumab</span> in combination with chemotherapy as first-line therapy for metastatic non-small-cell lung cancer: The Phase III POSEIDON Study. <i>J Clin Oncol</i> 41(6):1213-1227, 2023.doi:10.1200/JCO.22.00975</p></div></li><li class="topic__listitem"><span id="v68347670_zh" class="anchor"></span><div class="para"> <p>3.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/35320644/">Tawbi HA, Schadendorf D, Lipson EJ, et al</a>: <span class="genericDrug" data-showrollover="false">Relatlimab</span> and <span class="genericDrug" data-showrollover="false">nivolumab</span> versus <span class="genericDrug" data-showrollover="false">nivolumab</span> in untreated advanced melanoma.<i>N Engl J Med</i> 386(1):24–34, 2022. doi: 10.1056/NEJMoa2109970</p></div></li><li class="topic__listitem"><span id="v68347676_zh" class="anchor"></span><div class="para"> <p>4.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/29658856/">Gandhi L, Rodriguez-Abreu D, Gadgeel S, et al</a>: <span class="genericDrug" data-showrollover="false">Pembrolizumab</span> plus chemotherapy in metastatic non-small-cell lung cancer.<i>N Engl J Med</i> 378(22):2078–2092, 2018. doi: 10.1056/NEJMoa1801005</p></div></li><li class="topic__listitem"><span id="v80808142_zh" class="anchor"></span><div class="para"> <p>5.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31604537/">Ruffo E, Wu RC, Bruno TC, et al</a>: Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor. <i>Semin Immunol</i> 42:101305, 2019.doi:10.1016/j.smim.2019.101305</p></div></li><li class="topic__listitem"><span id="v80808145_zh" class="anchor"></span><div class="para"> <p>6.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/33859648/">Ning Z, Liu K, Xiong H</a>: Roles of BTLA in Immunity and Immune Disorders. <i>Front Immunol</i> 12:654960, 2021.doi:10.3389/fimmu.2021.654960</p></div></li><li class="topic__listitem"><span id="v80808148_zh" class="anchor"></span><div class="para"> <p>7.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/32601081/">Acharya N, Sabatos-Peyton C, Anderson AC</a>: Tim-3 finds its place in the cancer immunotherapy landscape. J Immunother Cancer.2020;8(1):e000911.doi:10.1136/jitc-2020-000911</p></div></li><li class="topic__listitem"><span id="v80808151_zh" class="anchor"></span><div class="para"> <p>8.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/34093577/">Hosseinkhani N, Derakhshani A, Shadbad MA, et al</a>: The role of V-domain Ig suppressor of T cell activation (VISTA) in cancer therapy: Lessons learned and the road ahead. <i>Front Immunol</i> 12:676181, 2021.doi:10.3389/fimmu.2021.676181</p></div></li><li class="topic__listitem"><span id="v80808154_zh" class="anchor"></span><div class="para"> <p>9.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/35745815/">Ordonez-Reyes C, Garcia-Robledo JE, Chamorro DF, et al</a>: Bispecific antibodies in cancer immunotherapy: A novel response to an old question. <i>Pharmaceutics</i> 14(6):1243, 2022.doi:10.3390/pharmaceutics14061243</p></div></li><li class="topic__listitem"><span id="v68347685_zh" class="anchor"></span><div class="para"> <p>10.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31590988/">Paz-Ares L, Dvorkin M, Chen Y, et al</a>: <span class="genericDrug" data-showrollover="false">Durvalumab</span> plus platinum-<span class="genericDrug" data-showrollover="false">etoposide</span> versus platinum-<span class="genericDrug" data-showrollover="false">etoposide</span> in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.<i>Lancet</i> 394(10212):1929–1939, 2019. doi: 10.1016/S0140-6736(19)32222-6</p></div></li><li class="topic__listitem"><span id="v68347680_zh" class="anchor"></span><div class="para"> <p>11.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/30345906/">Schmid P, Adams S, Rugo HS, et al</a>: <span class="genericDrug" data-showrollover="false">Atezolizumab</span> and <span class="genericDrug" data-showrollover="false">Nab-Paclitaxel</span> in advanced triple-negative breast cancer.<i>N Engl J Med</i> 379(22):2108–2121, 2018. doi: 10.1056/NEJMoa1809615</p></div></li></ul></div> </div> </section> </div> </section> <section id="v978250_zh" class="topic__section FHead" itemprop="associatedAnatomy" itemscope="" itemtype="http://schema.org/AnatomicalStructure"> <h2 id="Other_v978251_zh" class="topic__header--section"> <span id="v978251_zh" class="anchor"></span> 非特异性免疫治疗 </h2> <div class="topic__content"> <span id="v978252_zh" class="anchor"></span><div class="para"> <p><b>干扰素</b>（IFN-alpha、IFN-beta和IFN-gamma）是具有抗肿瘤和抗病毒活性的糖蛋白。根据剂量，干扰素可以增强或减弱 <a href="./{1596166C-F1D9-4F14-987C-5D93937CD3C6}.html" data-toggle="tooltip" title="宿主对肿瘤的反应" data-id="e78b452c-b060-4c35-a06e-e8b39a7947f0" data-itemid="1596166c-f1d9-4f14-987c-5d93937cd3c6">细胞免疫功能和体液免疫功能</a><span id="e78b452c-b060-4c35-a06e-e8b39a7947f0" class="d-none xref"> <span class="tooltip-container"> <a href="./{1596166C-F1D9-4F14-987C-5D93937CD3C6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 宿主对肿瘤的反应 </span> 对外源性抗原的免疫反应包括 体液机制（如抗体） 细胞机制 （参见 肿瘤抗原.) 大多数体液免疫反应不能抑制肿瘤生长。而T细胞、巨噬细胞和自然杀伤细胞等这些效应细胞具有相对有效的肿瘤杀伤能力。效应细胞活性由在其表面上呈递肿瘤特异性抗原（TSAs）或肿瘤相关抗原（TAAs）的其他细胞（这些细胞称为抗原呈递细胞）诱导，并由 细胞因子（例如白细胞介素，干扰素）支持。尽管效应细胞具有活性，但是宿主免疫反应可能无法控制肿瘤的发生和发展。 <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>。干扰素也可以抑制各种细胞的分裂和某些合成过程，包括造血干细胞。</p></div><span id="v68347690_zh" class="anchor"></span><div class="para"> <p>临床试验表明，干扰素在各种恶性肿瘤中具有抗肿瘤活性，包括毛细胞白血病、 <a href="./{D97A55ED-22B5-4886-BD09-192869C6E1DA}.html" data-toggle="tooltip" title="慢性髓性白血病（CML）" data-id="83df4269-9886-44c9-8e75-827f1eb2a48c" data-itemid="d97a55ed-22b5-4886-bd09-192869c6e1da">慢性粒细胞性白血病</a><span id="83df4269-9886-44c9-8e75-827f1eb2a48c" class="d-none xref"> <span class="tooltip-container"> <a href="./{D97A55ED-22B5-4886-BD09-192869C6E1DA}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 慢性髓性白血病（CML） </span> 慢性髓细胞白血病（CML）是一种多能干细胞发生恶性转化的克隆性增殖的疾病，导致成熟和未成熟粒细胞的生成显著增多。CML初期常没有症状，疾病进展隐匿并伴有一个非特异性的“良性”阶段（如不适、食欲减退及体重减轻），最终进展到加速期或急变期，并伴有更多的不良表现，如脾大、苍白、瘀斑和出血、发热、淋巴结肿大及皮肤病变。外周血涂片和骨髓穿刺检查以及Ph染色体阳性可以明确诊断。使用酪氨酸激酶抑制剂... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>、 <a href="./{10A0231F-DC70-43B2-950E-518BDBF50520}.html" data-toggle="tooltip" title="骨髓增殖性肿瘤概述" data-id="a460a592-cced-45af-9fc1-996db1cb88bd" data-itemid="10a0231f-dc70-43b2-950e-518bdbf50520">骨髓增生性肿瘤</a><span id="a460a592-cced-45af-9fc1-996db1cb88bd" class="d-none xref"> <span class="tooltip-container"> <a href="./{10A0231F-DC70-43B2-950E-518BDBF50520}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 骨髓增殖性肿瘤概述 </span> 骨髓增殖性肿瘤是骨髓干细胞的克隆性增殖，可表现为循环中血小板数量、红细胞（RBCs）或白细胞（WBCs）增多，可单独或联合出现，有时伴骨髓纤维化增加，并出现髓外造血（细胞生成在髓外进行）。根据这些异常，可分为 原发性血小板增多症（血小板增多）... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>、艾滋病相关 <a href="./{138DC6E3-04CF-4F6E-AA92-B62DE0A26FEF}.html" data-toggle="tooltip" title="卡波西肉瘤" data-id="a2e7b069-211e-404b-b067-992219010cbd" data-itemid="138dc6e3-04cf-4f6e-aa92-b62de0a26fef">卡波西肉瘤</a><span id="a2e7b069-211e-404b-b067-992219010cbd" class="d-none xref"> <span class="tooltip-container"> <a href="./{138DC6E3-04CF-4F6E-AA92-B62DE0A26FEF}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 卡波西肉瘤 </span> 卡波西肉瘤是由人疱疹病毒-8感染引起的多中心性血管肿瘤。 包括经典型、艾滋病型、地方型(非洲)和医源型(例如, 器官移植后)。诊断依靠活组织检查。浅表惰性的皮损可采用冷冻、电凝、切除或电子束治疗。放射治疗应用于皮损更广泛的病例。对于艾滋病相关的卡波西肉瘤，抗逆转录病毒治疗效果最佳。 （也可以参考 皮肤癌概述。） 卡波西肉瘤来源于因 人疱疹病毒8型（HHV-8）感染反应的内皮细胞。免疫抑制... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/k/a/p/kaposis_sarcoma_classic_high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="卡波西肉瘤" loading="lazy"> </span> </a> </span> </span>、 <a href="./{1EDD719C-18B1-42AF-B7AC-37865241A3E1}.html" data-toggle="tooltip" title="非霍奇金淋巴瘤" data-id="aa2d81fd-601d-46b8-8d1e-689754faa2bc" data-itemid="1edd719c-18b1-42af-b7ac-37865241a3e1">非霍奇金淋巴瘤</a><span id="aa2d81fd-601d-46b8-8d1e-689754faa2bc" class="d-none xref"> <span class="tooltip-container"> <a href="./{1EDD719C-18B1-42AF-B7AC-37865241A3E1}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 非霍奇金淋巴瘤 </span> 非霍奇金淋巴瘤是一组淋巴网状内皮细胞单克隆恶性增殖的异质性疾病，累及淋巴结、骨髓、脾脏、肝脏和胃肠道。临床表现常有外周淋巴结肿大。然而，有些患者不出现淋巴结肿大，但循环中出现异常的淋巴细胞。疾病很可能在出现时传播，诊断通常基于淋巴结或骨髓活检或两者均有。 管理策略可能包括观察和等待、化疗、靶向药物(如激酶抑制剂)和免疫疗法(如单克隆抗体、嵌合抗原受体T细胞);偶尔也会加上放射治疗。... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/1/3/m1310141-non-hodgkin-lymphoma-spl-high-edit_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="非霍奇金淋巴瘤" loading="lazy"> </span> </a> </span> </span>、 <a href="./{A3E9CBB2-F7B3-4B55-B48F-918F631D9495}.html" data-toggle="tooltip" title="多发性骨髓瘤" data-id="3a09b47b-c8d4-4ddf-88a4-80222db34d91" data-itemid="a3e9cbb2-f7b3-4b55-b48f-918f631d9495">多发性骨髓瘤</a><span id="3a09b47b-c8d4-4ddf-88a4-80222db34d91" class="d-none xref"> <span class="tooltip-container"> <a href="./{A3E9CBB2-F7B3-4B55-B48F-918F631D9495}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 多发性骨髓瘤 </span> 多发性骨髓瘤是一种恶性浆细胞病，产生单克隆免疫球蛋白，侵犯并破坏邻近的骨组织。常见临床表现包括引起疼痛和/或骨折的溶骨性病变、肾功能不全、高钙血症、贫血和反复感染。诊断通常需证实存在M蛋白（有时存在于尿液中，不存在于血清中，但很少完全缺失）和/或轻链蛋白尿，以及骨髓中过多的浆细胞。特异性治疗常包括传统化疗、糖皮质激素和一种或多种新药组合如蛋白酶体抑制剂(硼替佐米、卡非佐米、伊莎佐米)... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/u/l/multiple_myeloma_joyce_high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="多发性骨髓瘤" loading="lazy"> </span> </a> </span> </span>和 <a href="./{4F88EB2E-3537-4D01-AABA-94B754E26A55}.html" data-toggle="tooltip" title="卵巢癌、输卵管癌和腹膜癌" data-id="6d0099b6-f328-440c-a3cd-211edbf4ba3d" data-itemid="4f88eb2e-3537-4d01-aaba-94b754e26a55">卵巢癌</a><span id="6d0099b6-f328-440c-a3cd-211edbf4ba3d" class="d-none xref"> <span class="tooltip-container"> <a href="./{4F88EB2E-3537-4D01-AABA-94B754E26A55}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 卵巢癌、输卵管癌和腹膜癌 </span> 卵巢癌由于发现时多为晚期所以常为致命性。最常见的组织学 - 高级别浆液性上皮性卵巢癌 - 由于共同的临床特征，与输卵管癌和腹膜癌一起被认为是一个单一的临床实体。症状通常不存在或非特异性。 检查手段包括超声、CT或MRI和肿瘤标志物（如肿瘤抗原CA125）。确诊需组织学检查。分期靠手术分期。治疗需要子宫切除术、双侧输卵管-卵巢切除术、尽可能切除受累组织（细胞减少），通常还需要化疗。... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>(<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v80808159_zh" data-toggle="tooltip" title="非特异性免疫治疗参考文献" data-id="b24e9785-2709-487b-aacf-ef4ebc1c7276" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">1</a><span id="b24e9785-2709-487b-aacf-ef4ebc1c7276" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v80808159_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 非特异性免疫治疗参考文献 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>)。然而，干扰素可有严重的不良反应，如发热、不适、白细胞减少、脱发、肌痛、认知和抑郁的影响、心律失常，甲状腺功能减退。</p></div><span id="v978254_zh" class="anchor"></span><div class="para"> <p>某些<b>细菌佐剂</b>（例如，卡介苗[BCG]及其衍生物，灭活短小棒状杆菌混悬剂<i>Corynebacterium parvum</i>）具有抗肿瘤作用。它们已被用于治疗各种恶性肿瘤，无论添加或不添加肿瘤抗原，通常与强烈化疗或放射治疗一起使用。例如，将卡介苗直接注射到肿瘤组织中使 <a href="./{B016A78E-91B9-47FB-B3D0-EEE3F9C1386A}.html" data-toggle="tooltip" title="黑素瘤" data-id="0d43af04-505f-4165-8fd4-d40f79805dea" data-itemid="b016a78e-91b9-47fb-b3d0-eee3f9c1386a">黑色素瘤</a><span id="0d43af04-505f-4165-8fd4-d40f79805dea" class="d-none xref"> <span class="tooltip-container"> <a href="./{B016A78E-91B9-47FB-B3D0-EEE3F9C1386A}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 黑素瘤 </span> 恶性黑素瘤来源于色素沉着部位（皮肤、黏膜、眼或中枢神经系统）的黑素细胞。转移与皮肤侵袭的深度相关。肿瘤播散病例的预后很差。诊断依靠活组织检查。对于可切除的肿瘤，广泛切除术是标准方案。转移的病例需要系统治疗，但较难治愈。 （也可以参考 皮肤癌概述。） 2022 年，美国估计将发生约 99.780 例黑色素瘤新病例，估计造成 7650 人死亡（ 1, 2）。白人的终生风险约为 2... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/4/9/449-malignant-melanoma-nonsun-exposed-area-slide-23-springer-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="黑素瘤" loading="lazy"> </span> </a> </span> </span>消退， <a href="./{97D32D79-632B-4FBA-ABBC-E76620568087}.html#v1059849_zh" data-toggle="tooltip" title="浅表肿瘤" data-id="a38bc7f7-2f54-4584-8ac1-ef4a1d191d72" data-itemid="97d32d79-632b-4fba-abbc-e76620568087">浅表性膀胱癌</a><span id="a38bc7f7-2f54-4584-8ac1-ef4a1d191d72" class="d-none xref"> <span class="tooltip-container"> <a href="./{97D32D79-632B-4FBA-ABBC-E76620568087}.html#v1059849_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 浅表肿瘤 </span> 膀胱癌通常为移行细胞（泌尿道上皮）癌。患者通常出现血尿（最常见的），或刺激性排尿症状，如频率和/或紧迫性;随后出现尿路梗阻可引起疼痛。根据膀胱镜和活检诊断。 治疗包括电灼、经尿道电切、膀胱内灌注、根治性手术、化疗、外照射或联合疗法。 美国每年约有>83... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/c/0/1/c0105027-cystoscopy-bladder-cancer-science-photo-library-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="浅表肿瘤" loading="lazy"> </span> </a> </span> </span>的无病生存期延长，可能有助于延长 <a href="./{254F1AF2-71BD-4858-8DF6-D9AF69E77C56}.html" data-toggle="tooltip" title="急性髓系白血病（AML）" data-id="deddb3a0-4bc0-46e6-a6f8-b50c36c29530" data-itemid="254f1af2-71bd-4858-8df6-d9af69e77c56">急性粒细胞性白血病</a><span id="deddb3a0-4bc0-46e6-a6f8-b50c36c29530" class="d-none xref"> <span class="tooltip-container"> <a href="./{254F1AF2-71BD-4858-8DF6-D9AF69E77C56}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 急性髓系白血病（AML） </span> 在急性髓系白血病（AML）中，异常分化的、长寿命的髓系造血祖细胞发生恶性转化和不能控制的增殖，导致循环中出现大量不成熟的细胞，且正常骨髓被恶性细胞所取代。症状包括疲乏、面色苍白、易瘀伤及出血、发热和感染；髓外白血病浸润的症状仅出现在5%的患者（常为皮肤表现）。外周血涂片和骨髓检查可明确诊断。治疗包括诱导化疗以达到缓解，以及缓解后化疗（包括或不包括干细胞移植）以避免复发。 也见于... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/4/7/2/472-leukemia-cutis-localized-slide-5-springer-high_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="急性髓系白血病（AML）" loading="lazy"> </span> </a> </span> </span>、 <a href="./{4F88EB2E-3537-4D01-AABA-94B754E26A55}.html" data-toggle="tooltip" title="卵巢癌、输卵管癌和腹膜癌" data-id="093640c7-2763-4a1f-a2c0-65369112f343" data-itemid="4f88eb2e-3537-4d01-aaba-94b754e26a55">卵巢癌</a><span id="093640c7-2763-4a1f-a2c0-65369112f343" class="d-none xref"> <span class="tooltip-container"> <a href="./{4F88EB2E-3537-4D01-AABA-94B754E26A55}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 卵巢癌、输卵管癌和腹膜癌 </span> 卵巢癌由于发现时多为晚期所以常为致命性。最常见的组织学 - 高级别浆液性上皮性卵巢癌 - 由于共同的临床特征，与输卵管癌和腹膜癌一起被认为是一个单一的临床实体。症状通常不存在或非特异性。 检查手段包括超声、CT或MRI和肿瘤标志物（如肿瘤抗原CA125）。确诊需组织学检查。分期靠手术分期。治疗需要子宫切除术、双侧输卵管-卵巢切除术、尽可能切除受累组织（细胞减少），通常还需要化疗。... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>和 <a href="./{1EDD719C-18B1-42AF-B7AC-37865241A3E1}.html" data-toggle="tooltip" title="非霍奇金淋巴瘤" data-id="45cf6fae-c2db-472b-b2be-e340cfb90a1d" data-itemid="1edd719c-18b1-42af-b7ac-37865241a3e1">非霍奇金淋巴瘤</a><span id="45cf6fae-c2db-472b-b2be-e340cfb90a1d" class="d-none xref"> <span class="tooltip-container"> <a href="./{1EDD719C-18B1-42AF-B7AC-37865241A3E1}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> 非霍奇金淋巴瘤 </span> 非霍奇金淋巴瘤是一组淋巴网状内皮细胞单克隆恶性增殖的异质性疾病，累及淋巴结、骨髓、脾脏、肝脏和胃肠道。临床表现常有外周淋巴结肿大。然而，有些患者不出现淋巴结肿大，但循环中出现异常的淋巴细胞。疾病很可能在出现时传播，诊断通常基于淋巴结或骨髓活检或两者均有。 管理策略可能包括观察和等待、化疗、靶向药物(如激酶抑制剂)和免疫疗法(如单克隆抗体、嵌合抗原受体T细胞);偶尔也会加上放射治疗。... <span class="tooltip-readmore"> 阅读更多 </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/1/3/m1310141-non-hodgkin-lymphoma-spl-high-edit_zh.jpg?thn=0&sc_lang=zh&mh=160&mw=160" class="tooltip-Preview" alt="非霍奇金淋巴瘤" loading="lazy"> </span> </a> </span> </span>的药物诱导缓解时间 (<a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v80808159_zh" data-toggle="tooltip" title="非特异性免疫治疗参考文献" data-id="4909e423-237d-4383-bc5e-c6abebd04839" data-itemid="33507451-91a1-4adb-b50c-0ab017d4409e">2</a><span id="4909e423-237d-4383-bc5e-c6abebd04839" class="d-none xref"> <span class="tooltip-container"> <a href="./{33507451-91A1-4ADB-B50C-0AB017D4409E}.html#v80808159_zh"> <span class="tooltip-content"> <span class="tooltip-heading"> 非特异性免疫治疗参考文献 </span> 许多免疫治疗方法可直接针对肿瘤细胞，包括主动免疫和被动免疫。 （见 免疫治疗） 在被动性细胞免疫治疗中，特异性效应细胞被直接输入患者体内，不会被诱导。 淋巴因子激活的杀伤细胞（LAK细胞） 是由患者的内源性T细胞产生的，在细胞培养系统中，被提取的内源性T细胞经过淋巴因子IL-2的刺激而生长。产生的 LAK 细胞随后返回患者的血液中。动物研究表明，LAK细胞抗癌细胞的作用比原始内源性T细胞更强，这可能是因为它们的数量更多。LAK细胞在人体... <span class="tooltip-readmore"> 阅读更多 </span> </span> </a> </span> </span>)。</p></div> <section id="v80808158_zh" class="topic__section GHead"> <span></span> <h3 id="Other_v978251_zh_v80808159_zh" class="topic__header--subsection"> <span id="v80808159_zh" class="anchor"></span> 非特异性免疫治疗参考文献 </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v80808162_zh" class="anchor"></span><div class="para"> <p>1.<a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/31817234/">Arico E, Castiello L, Capone I, et al</a>: Type I interferons and cancer: An evolving story demanding novel clinical applications. <i>Cancers</i> (Basel) 11(12):1943, 2019.doi:10.3390/cancers11121943</p></div></li><li class="topic__listitem"><span id="v80808165_zh" class="anchor"></span><div class="para"> <p>2.<a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678944/">Gupta P, Chen C, Chaluvally-Raghavan P, Pradeep S</a>: B Cells as an immune-regulatory signature in ovarian cancer. <i>Cancers</i> (Basel) 11(7):894, 2019.doi:10.3390/cancers11070894</p></div></li></ul></div> </div> </section> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="MM358;MM346">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 看法 进行患者培训
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: 'MM358;MM346',
 title: '癌症的免疫治疗',
 itemGuid: '33507451-91a1-4adb-b50c-0ab017d4409e'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 版权所有 © 2023 Merck & Co., Inc., Rahway, NJ, USA 及其附属公司。保留所有权利。
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print collapsed">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{23EBB6DA-DEF4-445A-8A6B-49359DD3D9F2}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">肿瘤的免疫诊断</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" alt="" id="1b27eba0-91f0-430e-b5ba-1e55e093bac9_mobile" usemap="#1b27eba0-91f0-430e-b5ba-1e55e093bac9_mobile" width="0" height="0">
 <map name="1b27eba0-91f0-430e-b5ba-1e55e093bac9_mobile">
 <area shape="RECT" coords="177,320,263,364" href="https://play.google.com/store/apps/details?id=com.msd.professionalChinese&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
<area shape="RECT" coords="88,318,179,365" href="https://apps.apple.com/app/mo-sha-dong-zhen-liao-zhong/id1187944606" target="_blank" alt="iOS">
<area shape="RECT" coords="0,300,132,363" href="https://apps.appinchina.com.cn/details/com.msd.professionalChinese" target="_blank" alt="APPS in CHINA">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/zh_msd_mobile_pro_429.gif" alt="" id="1b27eba0-91f0-430e-b5ba-1e55e093bac9_tablet" usemap="#1b27eba0-91f0-430e-b5ba-1e55e093bac9_tablet" width="429" height="598">
 <map name="1b27eba0-91f0-430e-b5ba-1e55e093bac9_tablet">
 <area shape="RECT" coords="288,509,426,595" href="https://play.google.com/store/apps/details?id=com.msd.professionalChinese&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
<area shape="RECT" coords="147,509,287,596" href="https://apps.apple.com/app/mo-sha-dong-zhen-liao-zhong/id1187944606" target="_blank" alt="iOS">
<area shape="RECT" coords="0,509,146,594" https://apps.appinchina.com.cn/details/com.msd.professionalchinese"="" target="_blank" alt="APPS in CHINA">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/zh_msd_mobile_pro_262.gif" alt="" id="1b27eba0-91f0-430e-b5ba-1e55e093bac9_desktop" usemap="#1b27eba0-91f0-430e-b5ba-1e55e093bac9_desktop" width="262" height="365">
 <map name="1b27eba0-91f0-430e-b5ba-1e55e093bac9_desktop">
 <area shape="RECT" coords="177,320,263,364" href="https://play.google.com/store/apps/details?id=com.msd.professionalChinese&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
<area shape="RECT" coords="88,318,179,365" href="https://apps.apple.com/app/mo-sha-dong-zhen-liao-zhong/id1187944606" target="_blank" alt="iOS">
<area shape="RECT" coords="0,300,132,363" href="https://apps.appinchina.com.cn/details/com.msd.professionalChinese" target="_blank" alt="APPS in CHINA">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="下一个:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 顶部
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="菜单">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "阅读更多";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="话题" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="关闭" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>在该主题中</span>
 <span class="in-this-topic-togggle-btn" aria-label="在该主题中" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="版本切换">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="版本切换">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{3E29C424-F2D9-4E90-9F91-65F55E8C00D7}.html" target="_self" aria-label="资源">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Common.AriaLabels.SocialMediaShare"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="打印"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="邮件"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="更多的" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{3E29C424-F2D9-4E90-9F91-65F55E8C00D7}.html" target="_self" aria-label="首页">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="信息">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Common.AriaLabels.Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="
选择语言" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : cn2-p-sc-cd01
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="3350745191A14ADBB50C0AB017D4409E">
</div><div id="hiddentblcontents" style="display:none"></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>